Skip to content

Cinchocaine

Standardized Chemical Allergen — CARDIOVASCULAR SYSTEM

Also known as: dermacaine, dibucaine, dibucaine HCl, dibucaine hydrochloride, nupercaine, percamine

OfmFDA approvedATC C05AD04ATC D04AB02ATC N01BB06

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Cinchocaine is an ofm drug in the Standardized Chemical Allergen class catalogued in DrugCentral. DrugCentral lists 3 molecular targets, including SCN1A|SCN2A|SCN3A, SCN5A and SCN10A. Recorded indications include Itching of skin, Minor Skin Wound Pain and Skin irritation.

  • Approval status: ofm.
  • Drug class: Standardized Chemical Allergen.
  • Molecular targets: SCN1A|SCN2A|SCN3A, SCN5A and SCN10A (3 listed in DrugCentral).
  • Indications: Itching of skin, Minor Skin Wound Pain and Skin irritation.
  • ATC code: C05AD04 (Local anesthetics).
  • Molecular formula: C20H29N3O2; molecular weight 343.47 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (3)

  • Itching of skin
  • Minor Skin Wound Pain
  • Skin irritation

Contraindications (12)

  • Bleeding hemorrhoids
  • Conduction disorder of the heart
  • Decreased respiratory function
  • Deficiency of cholinesterase
  • Denuded skin
  • Disease of liver
  • Disorder of cardiovascular system
  • Disorder of mucous membrane
  • Kidney disease
  • Myasthenia gravis
  • Open wound
  • Seizure disorder

Mechanism & targets

Established pharmacologic classStandardized Chemical Allergen

Molecular targets (3)

TargetGeneActionActivity
Sodium channel alpha subunits; brain (Types I, II, III)SCN1A|SCN2A|SCN3AunknownIC50 5.85
Sodium channel protein type 5 subunit alphaSCN5Ablocker—
Sodium channel protein type 10 subunit alphaSCN10Ablocker—

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
—FDA——

ATC classification

ATC codeTherapeutic hierarchy
C05AD04CARDIOVASCULAR SYSTEM › VASOPROTECTIVES › AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE › Local anesthetics
D04AB02DERMATOLOGICALS › ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC. › ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC. › Anesthetics for topical use
N01BB06NERVOUS SYSTEM › ANESTHETICS › ANESTHETICS, LOCAL › Amides
S01HA06SENSORY ORGANS › OPHTHALMOLOGICALS › LOCAL ANESTHETICS › Local anesthetics
S02DA04SENSORY ORGANS › OTOLOGICALS › OTHER OTOLOGICALS › Analgesics and anesthetics

Reported adverse-event signals

Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.

MedDRA termLLR
Heart sounds125.7
Prolonged expiration118.8
Depressive symptom84.8
Respiration abnormal80.8
Appetite disorder80.7
Flank pain65.8
Rales65.3

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Cinchocaine is on its molecule page.

Molecular formulaC20H29N3O2
Molecular weight343.47 g/mol
CAS number85-79-0
InChIKeyPUFQVTATUTYEAL-UHFFFAOYSA-N
PubChem CID3025
CCCCOC1=NC2=CC=CC=C2C(=C1)C(=O)NCCN(CC)CC

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Cinchocaine used for?

DrugCentral lists the following indications for Cinchocaine: Itching of skin, Minor Skin Wound Pain and Skin irritation.

How does Cinchocaine work?

Its molecular targets in DrugCentral include SCN1A|SCN2A|SCN3A, SCN5A (blocker) and SCN10A (blocker).

What drug class does Cinchocaine belong to?

Cinchocaine is in the Standardized Chemical Allergen class.

What is the chemical formula of Cinchocaine?

Cinchocaine has the molecular formula C20H29N3O2 and a molecular weight of 343.47 g/mol.

Browse: all drugs starting with C · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

StatusOFM
First approval—
AgencyFDA
Targets3
Indications3
FormulaC20H29N3O2
DrugCentral ID859
Interactive profile